On February 24, 2021, Viracta Therapeutics, Inc. closed the transaction. The company raised $64,999,994 pursuant to Regulation D from 26 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.76 USD | -7.88% | -6.20% | +33.33% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.33% | 29.85M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- Viracta Therapeutics, Inc. announced that it has received $65 million in funding from a group of investors